SACCOMANO NICHOLAS A (President and CEO) sold 1.2% of their position (86.00 shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $357.46 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/24/2026ACC: 0001609284-26-000001
DirectorOfficer· President and CEO
Since Oct 2024
-86.00
Net shares
Net seller
$357.46
Total sold
1
Open market trades
0B · 1S
1
Total transactions
86.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−86.00
Price / share
$4.16
Trade value
$357.46
% of position
1.2%
3/23/2026
7.42K→7.33K
Total
Net shares
−86.00
Net value
-$357.46
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 3/23/2026 | S · Sale | −86.00 | $4.16 | $357.46 | 1.2% | 7.42K | 7.33K |
| Total | −86.00 | -$357.46 | ||||||
Derivative Transactions0
No derivative transactions reported